Home > Products > T

Featured China T Products

  • Tacrolimus  104987-11-3

    Chemical name: Tacrolimus CAS: 104987-11-3 Molecular formula: C44H69NO12 Molecular weight: 804.02 Appearance: White or white crystalline powder Content:99% ;Taca... >>>

    Shanghai ChemVia Co., Ltd    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Hangzhou Neway Chemicals Co., Ltd.    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Sunji & Co., Ltd.    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Shanghai Domen International Co., Ltd    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Kenloon International Limited    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Sinoway Industrial Co.LTD.    
  • Tacrolimus  104987-11-3

    ;Tacarolimus;3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,;(3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4... >>>

    Beijing Mediking Biopharm Co.,Ltd.    

Total 11021 Products,Showing 17 / 1103|‹   ‹‹   11 12 13 14 15 16 17 18 19 20 ›› ›|

Our other sites: ChinaChemNet - ChemNet - ChemNetCAS - PharmNet - ChinaTexNet - Toocle - Sunsirs - TexIndex - China Medical Device - Trading Services

© 1997- ChinaChemNet.com Corporation and its licensors. All rights reserved.